First-Line Management Of Youth Depression: A Randomised Placebo-Controlled Trial Of Fluoxetine And Cognitive Behavioural Therapy
Funder
National Health and Medical Research Council
Funding Amount
$1,316,648.00
Summary
The study aims to establish how to best treat adolescents and young adults when they present to mental health clinics with moderate-to-severe depression. There is, at present, considerable uncertainty as to whether young people should be started on antidepressant treatment at the same time as psychotherapy, or whether psychotherapy alone be commenced first. The study aims to clarify this important issue by implementing a trial that compares both treatment approaches.
Stress Vulnerability In Youth With Borderline Personality Disorder
Funder
National Health and Medical Research Council
Funding Amount
$873,689.00
Summary
Borderline personality disorder (BPD) is a severe mental disorder with adverse long-term outcomes, including suicide. BPD is characterised by vulnerability to stressful life events and catastrophic responses to stress. This study of youth early in the course of BPD examines the baseline biological characteristics of the stress response system, how these characteristics might be influenced by treatment and how this relates to treatment outcome. The findings will inform early intervention for BPD.
Neural Predictors Of Treatment Response In Youth Depression
Funder
National Health and Medical Research Council
Funding Amount
$519,596.00
Summary
Depression is the single greatest cause of disability and morbidity in young people. In order to reduce its substantial burden on individuals and society, there is a need to optimise the early provision of existing treatments. In this study, we will use cutting-edge neuroimaging technology to identify “biomarkers” in the brain that will help to more accurately determine which available treatments are likely to be most effective and safe for an individual patient.
Imagery As An Enhancer Of Cognitive Behaviour Therapy Outcomes For Social Anxiety Disorder: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$481,624.00
Summary
People with social Anxiety Disorder (SAD) have a severe fear of negative evaluation, which can be extremely distressing and debilitating. The proposed randomised controlled trial will evaluate a new imagery-enhanced group treatment for SAD that exploits the powerful relationship between mental imagery and emotion. The imagery-enhanced program is expected to demonstrate larger, more rapid, and longer-lasting improvements in SAD symptoms compared to existing best practice treatment.